Advertisement

Topics

NICE bars obesity pill from routine NHS use

07:12 EDT 31 Jul 2017 | PharmaTimes

Cost regulators for NHS treatments in England and Wales are standing by their position that Orexigen’s weight loss pill Mysimba can not be recommended as a cost-effective treatment option.

Original Article: NICE bars obesity pill from routine NHS use

NEXT ARTICLE

More From BioPortfolio on "NICE bars obesity pill from routine NHS use"

Quick Search
Advertisement